The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 5 Misconceptions about Immune Deficiency

5 Misconceptions about Immune Deficiency

August 16, 2018 • By Bharat Kumar, MD, MME, FACP, RhMSUS

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Moreover, primary immunodeficiencies are only one category. Secondary immunodeficiencies due to medications, malignancies or aging are not uncommon either. Many popular medications, such as certain anticonvulsants, may lead to potentially reversible antibody deficiencies. It’s unreasonable to assume a rheumatologist without additional training can identify a secondary immunodeficiency alone, but referral to a clinical immunologist with expertise certainly can help.

You Might Also Like
  • Immune Checkpoint Inhibitors & Immune-Related Adverse Events
  • Innate Immune Response Enters Center Stage for Inflammatory Eye Disease
  • A Duet of Bone and the Immune System
Explore This Issue
August 2018
Also By This Author
  • Basilisks in Rheumatology: The Hunt for Rheumatic Mysteries Shrouded in Enigmas & Wrapped in Puzzles

Misconception #3

Autoimmunity is incompatible with immunodeficiency.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It seems counterintuitive that an underactive immune system may lead to autoimmune manifestations. But this is a gross simplification of how our bodies work. The immune system is extraordinarily intricate and when one facet of the immune system does not work properly, it may very well trigger another facet to overcompensate.3 A classic example is early classical complement pathway deficiencies, which can trigger systemic lupus erythematosus (SLE) and SLE-like diseases.

In fact, from the clinical immunologist’s point of view, all autoimmune rheumatologic disease is on the same continuum as immunodeficiency. Unchecked and indiscriminate inflammation may predispose to recurrent or severe infections and other manifestations of immune deficiency. Some clinical data suggest that for a subset of patients with severe, uncontrolled rheumatoid arthritis, immunomodulatory treatment may, on balance, actually reduce the risk of recurrent infections.4

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Misconception #4

Immunodeficiency is a laboratory diagnosis.

As a clinical immunologist, this bugs me the most. Many labs can be ordered to assess the integrity of the immune system. But these are only a means to supplement clinical suspicions. Many patients in my clinic don’t have laboratory abnormalities but clearly have otherwise unexplainable immune problems, for which I provide treatment as best as I can. On the other side of the spectrum, I often see patients whose referring providers have identified laboratory abnormalities but have no clinical manifestations concerning for immunodeficiency.

Complicating matters is that qualitative deficits may be the primary drivers of many immunodeficiencies. In specific antibody deficiency, for example, the levels of immunoglobulins are within normal limits, but antibody titers demonstrate poor response to antigens. Conversely, patients may have low CD4 helper T cell counts but no appreciable qualitative defects causing clinical symptoms. I manage these patients conservatively, with the understanding that lab values should not dictate the quality of care.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Although I welcome all the business that comes to my clinic with abnormal lab values, this is a decidedly unwelcome hassle for patients and expenditure for the healthcare system at large. I would strongly encourage rheumatologists and others to focus on taking detailed histories and documenting infections, rather than ordering panels of screening labs beyond the widely available, cheap and meaningful IgG, IgA and IgM levels, as well as the complete blood count with differential.

Misconception #5

Treatment for immunodeficiencies are limited and ineffective.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: fellow, immune deficiency, InfectionIssue: August 2018

You Might Also Like:
  • Immune Checkpoint Inhibitors & Immune-Related Adverse Events
  • Innate Immune Response Enters Center Stage for Inflammatory Eye Disease
  • A Duet of Bone and the Immune System
  • Immune System No Longer Autonomous?

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.